Drug intelligence / Profile preview

Redsenol-1 Plus

Development stage: Unknown
Lead developer: Canada Royal Enoch Phytomedicine
Administration: Oral

Overview

Redsenol-1 Plus is a multi-component herbal supplement and botanical drug candidate developed by Canada Royal Enoch Phytomedicine Ltd. (Redsenol). It is formulated as an oral capsule containing 16 rare ginsenosides, including Rg3(R,S), Rh1(S,R), Rh2(R,S), Rk1, Rk3, Rg5, Rh3, Rh4, Rk2, aPPD(S,R), and aPPT(S,R). The product is primarily indicated for the management of cancer-related fatigue. It is currently being evaluated in a Phase 1 randomized, triple-blind, placebo-controlled clinical trial (NCT05664009) to assess its safety and efficacy in cancer patients experiencing fatigue. The formulation leverages the synergistic effects of multiple ginsenoside derivatives, which are bioactive compounds derived from Panax ginseng known for their potential anti-inflammatory and adaptogenic properties.

Brand names: Redsenol-1 PlusRedsenol1 PlusRedsenol 1 Plus
Other names: Redsenol-1 PlusRedsenol1 PlusRedsenol 1 Plus

Beyond the preview

Go deeper on Redsenol-1 Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Redsenol-1 Plus.

Explore the full profile